Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › LAURUSLABS

LAURUSLABS

Laurus Labs Limited
Mid-capPharma ↗

What the six lenses say about LAURUSLABS — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1507.4
2026-07-10
VWAP · 1Y anchor
₹1053
+43.1% from VWAP
P/E · TTM
91.6×
TTM EPS ₹16.5
52-week range
96%
position low→high
RSI(14)
61
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How LAURUSLABS’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD890›

The actual numbers

Price vs VWAP (1y)+43.1%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+34.4%
Price vs 50-EMA+9.7%
RSI(14)61
RS vs Nifty 500 · 3M+34.0%
RS vs sector · 3M+21.5%
52-week range96%
Volume vs 30d avg0.84×
Volume vs 60d avg0.89×
ATR(14) · volatility51.4
Bollinger width · vol contraction0.153
FundamentalD975›

The actual numbers

Return on equity (ROE)18.3%
Return on capital (ROCE)17.8%
Operating margin19.9%
Net margin13.1%
Revenue growth · YoY+22.7%
EPS growth · YoY+147.9%
Debt / equity0.48×

Full 8-quarter history in the financials table below.

ValuationD10›

The actual numbers

P/E (TTM)91.6×
TTM EPS₹16.5
52-week range96%
CatalystD434›

The actual numbers

Earnings & momentum32
Capital actions8
Governance91

Every filing in the corporate-announcements panel below.

FlowD450›

The actual numbers

Promoter holding27.5%
Delivery · 30d avg53.6%
Up/down-day asymmetry-0.1pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D8 + D4 ) ÷ 2 = 6.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
86
Conviction score 86/100 · avg-decile strength 6.0/10
Conviction score86/100›
TechnicalD8›
FundamentalD9›
ValuationD1›
CatalystD4›
FlowD4›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+2.3pp
-0.5pp
+5.6pp
+37.6pp
+45.9pp
+95.5pp
Nifty 500
Broad-market baseline
+1.8pp
-0.6pp
+5.0pp
+34.0pp
+40.8pp
+91.6pp
Sector
Own-sector index
—
—
+2.6pp
+21.5pp
+26.5pp
+73.8pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

LAURUSLABS daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1507.40+38.20

Relative strength

RS vs baseline · rebased to 100

LAURUSLABS ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
317.39+5.71

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)1,1951,2241,4151,7201,5701,6531,7781,812
↳ change QoQ—+2.4%+15.6%+21.6%-8.7%+5.3%+7.6%+1.9%
EBITDA (₹cr)174183295421382403480512
EBITDA margin14.5%14.9%20.8%24.5%24.3%24.4%27.0%28.3%
PAT (₹cr)132093233162194252282
↳ change QoQ—+57.3%+365.9%+150.7%-30.5%+19.8%+29.9%+11.9%
Net margin1.1%1.6%6.6%13.6%10.3%11.7%14.2%15.6%
EPS (₹)0.230.371.714.333.023.614.665.17
D/E————————
YoY growth · Mar '26Revenue +5.3% YoYPAT +21.0% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 8 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jun '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Jun '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds LAURUSLABS

Mutual funds holding LAURUSLABS (10)

FundWeightAUM ₹crGrade
Mirae Asset Large & Midcap Gr2.97%42,792
Axis Small Cap Fund Reg Gr0.79%27,840
Mirae Asset ELSS Tax Saver Reg Gr3.65%25,374
Mirae Asset Midcap Reg Gr3.45%19,003
HSBC Small Cap Fund Reg Gr1.03%16,877
Edelweiss Mid Cap Gr0.51%16,849
Axis Multicap Reg Gr0.77%9,938
Mahindra Manulife Multi Cap Reg Gr2.26%6,643
WhiteOak Capital Mid Cap Reg Gr2.19%5,732
SBI Healthcare Opportunities Reg Gr3.64%4,998

ETFs holding LAURUSLABS (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF6.38%
ICICI Pru Nifty Healthcare ETF5.43%
Aditya BSL Nifty Healthcare ETF5.11%
DSP Nifty Healthcare ETF5.11%
Axis NIFTY Healthcare ETF5.11%
Kotak Nifty 200 Momentum 30 ETF4.78%
ICICI Pru BSE Midcap Select ETF4.23%
Mirae Asset Nifty 500 Healthcare ETF4.20%
Motilal Oswal BSE Healthcare ETF3.59%
Groww Nifty 500 Momentum 50 ETF3.05%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma